AQST — Aquestive Therapeutics Share News
0.000.00%
Last trade - 00:00- $507.07m
- $549.32m
- $44.55m
Aquestive Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Aquestive Therapeutics Receives Conditional FDA Acceptance Of Proprietary Name Anaphylm™ For Lead Candidate Aqst-109 (Epinephrine Sublingual Film)
Brief: Aquestive Therapeutics Inc Says Received Notice From Nasdaq Informing Co That It Has Regained Compliance With Nasdaq
Brief: Aquestive Therapeutics Expands License And Supply Agreement With Pharmanovia For Libervant™ (Diazepam) Buccal Film To Additional Global Markets
Brief: Aquestive Therapeutics Holds No Any Deposits Or Securities At Silicon Valley Bank
U.S. RESEARCH ROUNDUP- Ameresco, Bioxcel Therapeutics, Roblox
Aquestive Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Aquestive Therapeutics Reports Fourth Quarter & Full Year 2022 Financial Results And Provides Business Update On Key 2023 Objectives
Aquestive Therapeutics Inc expected to post a loss of 23 cents a share - Earnings Preview
Brief: Aquestive Therapeutics Inc Received Notice Of Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: Aquestive Therapeutics Announces Completion Of FDA End-Of-Phase 2 Meeting For Aqst-109 (Epinephrine Sublingual Film)
Brief: Aquestive Therapeutics Reports Third Quarter 2022 Financial Results And Provides Business Update
Aquestive Therapeutics Inc reports results for the quarter ended in September - Earnings Summary
Aquestive Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
Brief: Assertio Holdings Signs Exclusive License For Sympazan Oral Film From Aquestive Therapeutics
Brief: Aquestive Therapeutics Licenses Sympazan® (Clobazam) Oral Film To Assertio Holdings, Inc.
Aquestive gains as district court dismisses antitrust claims
Brief: Aquestive Says U.S. District Court Entered Order Dismissing All Claims Against Co In Certain Lawsuit
U.S. STOCKS ON THE MOVE-Aquestive, Bassett Furniture, Amgen